AI assistant
STAAR SURGICAL CO — Director's Dealing 2024
Mar 14, 2024
31996_dirs_2024-03-14_07201397-2434-489b-bd46-efee3b17375c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2024-03-12
Reporting Person: Foust Warren (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-12 | Restricted Stock Units | $0.00 | A | 24525 | Acquired | Common Stock (24525) | Direct | |
| 2024-03-12 | Common Stock Options | $37.64 | A | 21966 | Acquired | 2034-03-11 | Common Stock (21966) | Direct |
Footnotes
F1: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F2: RSUs granted to the Reporting Person on March 12, 2024. RSUs will vest as to 1/3 (8,175 shares) on March 12, 2025, 1/3 (8,175 shares) on March 12, 2026, and 1/3 (8,175 shares) on March 12, 2027.
F3: Stock options granted to the Reporting Person on March 12, 2024. Options will vest and become exercisable as to 1/3 (7,322 shares) on March 12, 2025, with the remaining 2/3 (14,644 shares) vesting and becoming exercisable monthly over the following 24 months in equal amounts on a monthly basis. In the event such amount does not evenly divide into 24 months, the remaining balance of options will vest and become exercisable on March 12, 2027.